SGHT — Sight Sciences Cashflow Statement
0.000.00%
- $425.62m
- $373.31m
- $79.87m
- 47
- 16
- 93
- 51
Annual cashflow statement for Sight Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.7 | -63 | -86.2 | -55.5 | -51.5 |
| Depreciation | |||||
| Non-Cash Items | 1.18 | 14.1 | 15.3 | 16.9 | 19.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.784 | -4.33 | -5.7 | -9.13 | 9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -32.2 | -52.5 | -76 | -47.2 | -22.4 |
| Capital Expenditures | -0.953 | -0.813 | -0.97 | -0.791 | -0.385 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.953 | -0.813 | -0.97 | -0.791 | -0.385 |
| Financing Cash Flow Items | -0.509 | -4.51 | 0 | -0.224 | -0.261 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 73.4 | 253 | 1.25 | 1.1 | 4.96 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 40.3 | 199 | -75.7 | -46.9 | -17.8 |